Objectives: To examine the distribution of cortical Lewy bodies (LB) and th
eir contribution to the clinical syndrome in dementia with LB (DLB) and to
address their relationship to the pathologic markers of AD and PD. Methods:
We studied 25 cases meeting neuropathologic criteria for DLB: 13 cases wit
hout AD (Braak stage I or II) and 12 cases with concomitant AD changes (Bra
ak stages III to V). Age at onset, disease duration, and clinical symptoms
were reviewed for each case. We quantified the regional distribution of LB
in substantia nigra, paralimbic areas (cingulate gyrus, insula, entorhinal
cortex, and hippocampus), and neocortex (frontal and occipital association
areas) using anti-alpha-synuclein immunostaining. We compared the LB pathol
ogy between groups of patients with different symptoms at onset or with spe
cific clinical phenotypes. Results: There were no significant differences i
n clinical symptoms or LB density between cases with or without concomitant
AD. LB density showed a consistent gradient as follows: substantia nigra >
entorhinal cortex > cingulate gyrus > insula > frontal cortex > hippocampu
s > occipital cortex. LB density in substantia nigra and neocortex was not
significantly different in cases that started with parkinsonism compared wi
th those that started with dementia. There were no significant differences
in LB density in any region among patients with or without cognitive fluctu
ations, visual hallucinations, delusions, recurrent falls, or parkinsonism.
Duration of the disease correlated with a global LB burden for each case (
p = 0.02) but did not-correlate with LB density in any individual area. Par
alimbic and neocortical LB density were highly correlated with each other (
p < 0.0001), but neither of these correlated well with the number of LB in
substantia nigra. LB density did not correlate with Braak stage or frequenc
y of neuritic plaques. Conclusions: There is a consistent pattern of vulner
ability to LB formation across subcortical, paralimbic, and neocortical str
uctures that is similar for DLB cases with or without-concomitant AD. Paral
imbic and neocortical LB do not correlate with LB in substantia nigra, sugg
esting that DLB should not be considered just a severe form of PD, LB densi
ty correlates weakly with clinical symptoms and disease duration.